SCHEMBL15823257

SCHEMBL15823257

COc1cc(NC(=O)CCCc2ccc(-c3ccccc3)c(NC(=O)O)c2)c(Cl)cc1C=O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.45
CHEK1 O14757 2/20 0.44
HPGD P15428 2/20 0.43
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
LTB4R Q15722 1/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
TRPV1 Q8NER1 1/20 0.40
PLAAT3 P53816 1/20 0.40
PLAAT5 Q96KN8 1/20 0.40
PLAAT2 Q9NWW9 1/20 0.40
PLAAT4 Q9UL19 1/20 0.40
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
LMNA P02545 1/20 0.39
HDAC1 Q13547 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15822677 0.88 ALDH1A1 (0.41) POLBRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL101634 0.88 POLB (0.46) POLBCHEK1HPGDRAB9ANPC1
Iodide SCHEMBL100439 0.84 CHRM3 (0.41) POLBCHEK1HPGDRAB9ANPC1
SCHEMBL99533 0.84 CHRM3 (0.39) POLBCHEK1HPGDTRPV1
SCHEMBL15823225 0.83 NPC1 (0.45) POLBHPGDRAB9ANPC1SMN1; SMN2
Iodide SCHEMBL100739 0.82 CHRM3 (0.41) CHEK1HPGDRAB9ANPC1
SCHEMBL15823698 0.82 NPC1 (0.42) POLBHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL100422 0.82 HPGD (0.51) POLBCHEK1HPGDRAB9ANPC1
Iodide SCHEMBL661449 0.81 CHRM3 (0.37) POLBCHEK1HPGDSMN1; SMN2
SCHEMBL99878 0.81 KDM4E (0.43) POLBCHEK1HPGDRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2934594-B1 CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES . ALMIRALL SA (ES) 2019-09-04 EP disclosed
EP-2934594-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY Almirall, S.A. (ES) 2015-10-28 EP disclosed
WO-2014095920-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY ALMIRALL, S.A. (ES) 2014-06-26 WO disclosed